tiprankstipranks
Trending News
More News >
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ:ARTV
US Market

Artiva Biotherapeutics, Inc. (ARTV) Income Statement

Compare
426 Followers

Artiva Biotherapeutics, Inc. Income Statement

Last quarter (Q3 2025), Artiva Biotherapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Artiva Biotherapeutics, Inc.'s net income was $-21.53M. See Artiva Biotherapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 251.00K$ 33.49M$ 4.93M$ 2.00M$ 0.00
Gross Profit
$ 251.00K$ 33.49M$ 4.93M$ 2.00M$ 0.00
Operating Expenses
$ 67.53M$ 64.16M$ 64.76M$ 55.27M$ 18.27M
Depreciation and Amortization
$ 2.43M$ 2.27M$ 1.16M$ 248.00K$ 73.00K
EBITDA
$ -64.85M$ -28.41M$ -58.67M$ -71.58M$ -17.52M
Operating Income
$ -67.28M$ -30.67M$ -59.83M$ -53.27M$ -18.27M
Other Income/Expenses
$ 8.79M$ 3.05M$ 1.49M$ -18.55M$ 280.00K
Pretax Income
$ -58.49M$ -27.62M$ -58.34M$ -71.83M$ -17.99M
Net Income
$ -58.49M$ -27.70M$ -58.39M$ -71.83M$ -17.99M
Per Share Metrics
Basic EPS
$ -5.20$ -1.19$ -3.32$ -4.08$ -1.02
Diluted EPS
$ -5.20$ -1.19$ -3.32$ -4.08$ -1.02
Weighted Average Shares Outstanding
24.36M 23.28M 17.58M 17.58M 17.58M
Weighted Average Shares Outstanding (Diluted)
24.36M 23.28M 17.58M 17.58M 17.58M
Currency in USD

Artiva Biotherapeutics, Inc. Earnings and Revenue History